PHARMACEUTICAL LAW PUBLICATION nº 76

Interruption of supply or the withdrawal of medicines from the market and competition rules.

Henar González Durántez y Pilar Carrasco del Olmo

 

2021 versión of Pharmaceutical Industry Code  of Best Practices.

Teresa Paz-Ares Rodríguez, Beatriz Cocina Arrieta y Nuria Porxas Roig

 

Regulatory framework aplicable to observational studies with medicines for human use foreseen in Royal Decree 957/2020 and the impact on the regimen aplicable  to patient support programs.

Jordi Faus Santasusana y Lluís Alcover Llubià

 

Civil liability regime for defective products in case of damages caused by mass vaccination

Kiko Carrión García de Parada

 

Possibility of establishing a Compensation Fund in Spain to compensate COVID-19 vaccine damages.

Paulino Fajardo Martos, Lourdes Fraguas Gadea y Milagros Sanz Parrilla

 

Vaccines in pandemic time.

Fundación CEFI

 

Click here to access the publication

This post is also available in: Spanish

Otras noticias

PHARMACEUTICAL LAW PUBLICATION nº 76

Interruption of supply or the withdrawal of medicines from the market and competition rules. Henar González Durántez y Pilar Carrasco del Olmo   2021 versión of Pharmaceutical Industry Code  of Best Practices. Teresa Paz-Ares Rodríguez, Beatriz Cocina Arrieta y Nuria

Leer Más >>

WORLD INTELLECTUAL PROPERTY DAY– 26 APRIL

In light of the current COVID-19 health crisis, it is an apt moment to highlight the importance of intellectual property. Intellectual and industrial property, among others, allow us to turn ideas into concrete projects that create value, wealth, jobs, and

Leer Más >>